Munafa Stock Market Course + Intraday & FNO calls 
Xtl Biopharmaceuticals (XTLB) Technical (Analysis) Reports Xtl Biopharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Complete & easy to understand technical analysis of Xtl Biopharmaceuticals (XTLB)
Technical Analysis Report for NASDAQ stock XTLB Xtl Biopharmaceuticals. Dated: 24 Mar 2026 Updated Daily. Stock trades under Health Care Deals in Major Pharmaceuticals in NASDAQ stock exchange
If you are looking for Tomorrow's Movement Predictions for NASDAQ stock XTLB Xtl Biopharmaceuticals then click here. or read Experts views on Xtl Biopharmaceuticals or Forecast & share price targets of Xtl Biopharmaceuticals
Xtl Biopharmaceuticals Opened at 0.58 and Closed at: 0.65, which is 10.77% of previous session's close. It moved within a range of 0.57 and 0.66
The session was a Bullish session with an average volume of 44600, which is 50.22% of previous session's volumes.
- Even though the stock has shown an up move, but the short term trend of the stock remains negative and in a downtrend.
Support for tomorrow is 0.61 and resistance for tomorrow is 0.7
These support and resistance points are valid for the first 5-15 minutes charts
Above are simple pivot point calculations. For a list of much stronger support and resistance levels click here. These are way more stronger support and resistance levels, and mark trend reversals and are Support & Resistance levels recommended by experts.
Support for tomorrow's hourly charts is 0.59, 0.54 resistance for tomorrow's hourly charts is 0.68, 0.72
10 Day SMA for Xtl Biopharmaceuticals (XTLB) is 0.62 and stock is trading above these levels. This is a good sign for its short term trend
20 Day SMA for Xtl Biopharmaceuticals (XTLB) is 0.69 and the stock is trading below these levels. This is not a good sign for its mid term trend
50 Day SMA for Xtl Biopharmaceuticals (XTLB) is 0.83 and the stock is trading below these levels. This is not a good sign for its mid to long term trend
100 Day SMA is 0.84 and the stock is trading below these levels. This is not a good sign for its long term trend
200 Day SMA Xtl Biopharmaceuticals is 1.09 and stock is trading below these levels. This is not a good sign for its long term trend
20 DMA of Xtl Biopharmaceuticals is at 0.69 and 200 DMA is at 1.09, while 50 DMA and 100 DMA are at 0.83 and 0.84 respectively
Xtl Biopharmaceuticals (XTLB) moving average of 20 SMA is at 0.69 and 20 EMA is at 0.7
| Date | Closing Price | 20 SMA | 20 EMA |
| 24 Tue Mar | 0.65 | 0.69 | 0.7 |
| 23 Mon Mar | 0.58 | 0.7 | 0.7 |
| 20 Fri Mar | 0.59 | 0.71 | 0.71 |
| 19 Thu Mar | 0.60 | 0.73 | 0.72 |
| 17 Tue Mar | 0.61 | 0.74 | 0.73 |
| 16 Mon Mar | 0.62 | 0.75 | 0.74 |
Xtl Biopharmaceuticals (XTLB) moving average of 50 SMA is at 0.83 and 50 EMA is at 0.76
| Date | Closing Price | 50 SMA | 50 EMA |
| 24 Tue Mar | 0.65 | 0.83 | 0.76 |
| 23 Mon Mar | 0.58 | 0.83 | 0.76 |
| 20 Fri Mar | 0.59 | 0.83 | 0.77 |
| 19 Thu Mar | 0.60 | 0.83 | 0.78 |
| 17 Tue Mar | 0.61 | 0.84 | 0.79 |
| 16 Mon Mar | 0.62 | 0.84 | 0.8 |
Xtl Biopharmaceuticals (XTLB) moving average of 100 SMA is at 0.84 and 100 EMA is at 0.84
| Date | Closing Price | 100 SMA | 100 EMA |
| 24 Tue Mar | 0.65 | 0.84 | 0.84 |
| 23 Mon Mar | 0.58 | 0.84 | 0.84 |
| 20 Fri Mar | 0.59 | 0.85 | 0.85 |
| 19 Thu Mar | 0.60 | 0.86 | 0.86 |
| 17 Tue Mar | 0.61 | 0.86 | 0.87 |
| 16 Mon Mar | 0.62 | 0.87 | 0.88 |
Xtl Biopharmaceuticals (XTLB) moving average of 200 SMA is at 1.09 and 200 EMA is at 1.09
| Date | Closing Price | 200 SMA | 200 EMA |
| 24 Tue Mar | 0.65 | 1.09 | 1.09 |
| 23 Mon Mar | 0.58 | 1.09 | 1.09 |
| 20 Fri Mar | 0.59 | 1.09 | 1.1 |
| 19 Thu Mar | 0.60 | 1.09 | 1.11 |
| 17 Tue Mar | 0.61 | 1.1 | 1.12 |
| 16 Mon Mar | 0.62 | 1.1 | 1.13 |
Xtl Biopharmaceuticals has performed better than 111 Inc in short term. Holding Xtl Biopharmaceuticals could be a better choice for now!
Kura Oncology has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Kura Oncology, about 15.05% more returns!
Agios Pharmaceuticals has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Agios Pharmaceuticals, about 12.04% more returns!
Atyr Pharma has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Atyr Pharma, about 6.95% more returns!
Alkermes Plc has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Alkermes Plc, about 3.81% more returns!
Ani Pharmaceuticals has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Ani Pharmaceuticals, about 14.33% more returns!
Alphatec Holdings has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Alphatec Holdings, about 3.1% more returns!
Xtl Biopharmaceuticals has performed better than Autolus Therapeutics in short term. Holding Xtl Biopharmaceuticals could be a better choice for now!
Aytu Bioscience has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Aytu Bioscience, about 35.49% more returns!
Nektar Therapeutics has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Nektar Therapeutics, about 25.39% more returns!
Xtl Biopharmaceuticals has performed better than Organogenesis Holdings in short term. Holding Xtl Biopharmaceuticals could be a better choice for now!
Catalyst Pharmaceuticals has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Catalyst Pharmaceuticals, about 14.12% more returns!
Champions Oncology has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Champions Oncology, about 18.92% more returns!
Riot Blockchain has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Riot Blockchain, about 5.6% more returns!
Sarepta Therapeutics has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Sarepta Therapeutics, about 12.22% more returns!
Trinity Biotech has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Trinity Biotech, about 0.079999999999998% more returns!
Urogen Pharma has performed better than Xtl Biopharmaceuticals in short term. You could have earned much better returns by investing in Urogen Pharma, about 3.86% more returns!
Xtl Biopharmaceuticals has performed better than Jaguar Health in short term. Holding Xtl Biopharmaceuticals could be a better choice for now!
Xtl Biopharmaceuticals has performed better than Xeris Pharmaceuticals in short term. Holding Xtl Biopharmaceuticals could be a better choice for now!
Xtl Biopharmaceuticals Technical analysis of indicators
Price action analysis of Xtl Biopharmaceuticals (XTLB) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Xtl Biopharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Xtl Biopharmaceuticals in short term and the sell signal is strong.
Xtl Biopharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be moving up
CCI has generated a buy signal for Xtl Biopharmaceuticals in short term and BUY signal is strong.
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Xtl Biopharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 0.62 and Xtl Biopharmaceuticals XTLB stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Xtl Biopharmaceuticals XTLB stock. Volume based technical analysis of Xtl Biopharmaceuticals XTLB stock is negative.
Xtl Biopharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Tomorrow's Predictions
You should also read Tomorrow's Movement Predictions for NASDAQ stock XTLB Xtl Biopharmaceuticals These predictions are based on various factors, are easy to understand, and upto 75% accurate!
And XTLB Experts View which covers a lot of information including buying and selling signals
XTLB future forecast & share price targets
You can also take a look at the Charts and indicator analysis here Announcements & NEWS by Xtl Biopharmaceuticals or View Candle Stick Charts here
Quick Charts: Renko Point & Figure Just IntraDay All Indicators Weekly Monthly All in One Eagle View MACD & ADX
Videos related to: Xtl Biopharmaceuticals (XTLB) Technical (Analysis) Reports Xtl Biopharmaceuticals ["Technical Analysis"] Reports -NASDAQ Stock Exchange MunafaSutra.com
Hindi Basics How To Trade In FnO Futures Options Stock Market
Hindi Video The Truth Of Stock Markets That Everyone Is Hiding From You
- NASDAQ Screeners
- NASDAQ Daily Screener
- NASDAQ Weekly Screener
- NASDAQ Monthly Screener
- Support & Resistance
- NASDAQ Shares Near Support
- NASDAQ Shares Near Resistance
